Kafle and his colleagues are working to improve American national health security by bolstering the supply of market-competitive, commercial U.S.-made active pharmaceutical ingredients.
Kafle and his colleagues are working to improve American national health security by bolstering the supply of market-competitive, commercial U.S.-made active pharmaceutical ingredients.
Kafle and his colleagues are working to improve American national health security by bolstering the supply of market-competitive, commercial U.S.-made active pharmaceutical ingredients.
Kafle and his colleagues are working to improve American national health security by bolstering the supply of market-competitive, commercial U.S.-made active pharmaceutical ingredients.
Look back at some of UMSL Daily’s top stories from the past year, including the launch of the UMSL School of Engineering and the naming of the Ed G. Smith College of Business, along with continuing campus transformation.
The new labs will play a key role in efforts to safeguard national health security and solidify the St. Louis region as a hub for domestic API production of critical medications.
The new labs will play a key role in efforts to safeguard national health security and solidify the St. Louis region as a hub for domestic API production of critical medications.
The new labs will play a key role in efforts to safeguard national health security and solidify the St. Louis region as a hub for domestic API production of critical medications.
The new funding will support research and development in the center’s new state-of-the-art lab, which is scheduled to open next month in UMSL’s Science Complex.
The new funding will support research and development in the center’s new state-of-the-art lab, which is scheduled to open next month in UMSL’s Science Complex.
The new funding will support research and development in the center’s new state-of-the-art lab, which is scheduled to open next month in UMSL’s Science Complex.
APIIC and its partners have been awarded $14 million in federal funding to lead the development and domestic production of three critical APIs used in the treatment of asthma, diabetes and anxiety disorders.
APIIC and its partners have been awarded $14 million in federal funding to lead the development and domestic production of three critical APIs used in the treatment of asthma, diabetes and anxiety disorders.
APIIC and its partners have been awarded $14 million in federal funding to lead the development and domestic production of three critical APIs used in the treatment of asthma, diabetes and anxiety disorders.
Sobolik also recapped some of the university’s many successes over the past year during the event at the Blanche M. Touhill Performing Arts Center.